Observatoire des droits humains (anglais seulement)

FDA’s new regulations underscore the complexity around screening for women with dense breasts

(Version anglaise seulement)

par Nancy Kressin, Emeritus Professor of Medicine, Boston University
Christine M. Gunn, Assistant Professor of Health Policy and Clinical Practice, Dartmouth College
Priscilla J. Slanetz, Professor of Radiology, Boston University
Tracy A. Battaglia, Associate Director of Cancer Care Equity, Yale Cancer Center, Yale University

The FDA’s rule change requires that all women in the US be informed about breast density and options for supplemental screening.

Lire l'article complet